The invention describes new solvates of lercanidipine hydrochloride with organic solvents, new crystalline Forms (III) and (IV) of lercanidipine hydrochloride obtained from said solvates by removing solvation solvents, and pharmaceutical compositions containing as active agent at least one of the crystalline Forms (III) and (IV) of lercanidipine hydrochloride.
展开▼